Issuer Flash: Nan Shan Life Insurance

Report date: 2026-10-20 Event date: 2026-09-30 Event title: September 2026 monthly and nine-month earnings

1. Flash Conclusion

Nan Shan Life Insurance, a Taiwan life insurer whose credit depends on the assets and capital supporting long-duration policyholder liabilities, reported September net income of NT$2.680bn and nine-month net income of NT$43.182bn in its official monthly financial information. September first-year premiums (FYP) were NT$9.353bn, taking the nine-month total to NT$107.017bn. Positive earnings in both periods provide a useful subsequent checkpoint after the H1 financial statements, but the short statement does not establish an improvement in recurring insurance profitability, capital headroom or liquidity.

The credit view therefore remains that of a substantial insurance franchise with material FX, asset-liability-management (ALM) and market-risk constraints. The new earnings contribution is directionally supportive; it is insufficient to conclude that those constraints have eased. For subordinated bondholders, positive reported income also does not change ranking or establish the capacity to pay coupons or redeem capital instruments. The next decision-relevant evidence is the full quarterly financial report and its capital, investment and insurance-liability disclosures.

2. What Was Announced

The issuer's English financial-information page links a one-page statement headed “Monthly 2026.9” and “Year-To-Date 2026.9.” It reports premiums, pretax income, net income and cumulative EPS. The official page and PDF inspected for this update did not provide an independent posting date. The Event date above is consequently the September period end, not a confirmed release date; the document was verified on 20 October 2026.

Source: Nan Shan Life official monthly financial information, September 2026, p.1. The statement does not specify a consolidated or standalone accounting scope and contains no audit/review opinion or reconciliation to financial statements.

These are two different observation windows: September alone and the cumulative nine months. The cumulative amounts are not additional to the monthly amounts. Both profit measures are positive in September and year to date, but the statement contains no corresponding 2025 figures. It therefore supports a positive level of reported earnings, rather than a quantified year-on-year improvement. September income should not be annualised or treated as a representative monthly run rate for an insurer exposed to financial-market movements.

3. Credit Read-Through

The first implication is continued positive reported earnings beyond the period covered by the August H1 flash. Profit can contribute to loss absorption if it is retained and remains available under applicable accounting and regulatory rules. That is a conditional benefit: this statement does not show distributions, changes in other comprehensive income (OCI), regulatory adjustments or the movement in eligible capital. A positive income line alone cannot demonstrate that the insurer has built a larger buffer against currency, interest-rate or credit-spread stress.

The earnings source matters as much as the amount. The H1 flash identified a broadly stable insurance-service contribution alongside a much larger change in the financial result, and highlighted the influence of FX and valuation movements. The September statement provides no split between insurance-service earnings, investment performance, insurance-finance effects, hedging costs or reserve movements. The nine-month net income figure consequently cannot establish that underwriting economics improved or that the H1 financial-result recovery is recurring. It gives a timely directional update while leaving the existing earnings-quality question open.

Comparability also limits the analysis. The H1 flash used consolidated financial statements under the IFRS 17 / IFRS 9 presentation, with restated comparatives. The monthly document does not identify its consolidation scope or explain its accounting relationship to those statements. Subtracting the H1 consolidated net profit from this nine-month monthly figure would produce an apparent Q3 result without a verified common basis. This flash does not make that calculation. A quarterly earnings bridge should wait for the issuer's financial statements or an explicit reconciliation.

FYP confirms reported new-premium production, but it is not equivalent to insurance revenue, underwriting profit or cash available to bondholders. The NT$107.017bn year-to-date figure does not disclose the product mix, guarantees, acquisition costs, new-business margin or capital consumed by those sales. Protection-oriented, investment-linked, foreign-currency and savings products can have different credit implications. Without those distinctions or a like-basis comparison, the premium figure cannot establish improved franchise momentum or better risk-adjusted new-business economics. The relevant test is whether production adds profitable future service earnings without increasing guarantees, currency mismatch or capital pressure disproportionately.

The update also leaves the H1 liquidity follow-up unresolved. The August flash drew attention to lower cash and negative operating cash flow, while explaining that those figures alone did not establish a shortfall. This monthly statement supplies no September cash balance, cash-flow statement, investment-liquidity information, surrender data or collateral requirements. Net income cannot be substituted for those measures: accounting gains may not generate immediately usable cash, and insurance or hedge cash needs may arise separately from reported earnings. Neither a liquidity improvement nor a new deterioration can be inferred from this statement.

For bond investors, the practical implication is to retain the distinction between issuer earnings, policyholder protection and the terms of subordinated capital. The September profit supports continued monitoring rather than a stronger security-level conclusion. The statement announces no change to bond ranking, coupon restrictions, loss absorption or redemption approvals. It also supplies no basis for a new rating or relative-value judgment. A decision to increase exposure would require evidence on economic capital and liquidity resilience as well as the relevant security's terms and market valuation.

4. What To Watch Next

• Obtain the next quarterly financial statements and a common-scope earnings comparison. Separate the insurance-service result from investment, insurance-finance, FX, hedge and reserve effects before judging persistence.
• Check capital ratios and numerical headroom, OCI, FX valuation reserves and the movement in equity. Positive monthly income does not answer the existing solvency-buffer question.
• Reconcile FYP with product mix, new-business profitability and contractual service margin (CSM). The monthly statement contains neither CSM nor evidence that new sales improve future risk-adjusted earnings.
• Revisit cash, operating cash flow, investment liquidity, surrender behaviour and collateral or hedge needs. These remain necessary to interpret the earlier H1 cash movements.
• Establish the monthly statement's accounting/consolidation basis and confirm comparable prior-period data before calculating growth or a stand-alone Q3 result. The independent September release date also remains unconfirmed.

5. Sources

• Nan Shan Life, Financial Information: Monthly 2026.9 / Year-To-Date 2026.9, p.1, verified 20 October 2026. Primary source for all new earnings and premium figures; period September 2026, independent publication date unconfirmed.
• Nan Shan Life, Financial Information, 2026 monthly selection, verified 20 October 2026. Official route to the September statement.
• issuer_summary/issuers/nan_shan_life_insurance/current/nan_shan_life_insurance_issuer_flash_q2_1h_2026_results_20260828.md and issuer_summary/issuers/nan_shan_life_insurance/current/nan_shan_life_insurance_issuer_summary_20260514.md. Prior internal credit context only; H1 consolidated figures are not used to derive a Q3 monthly-reporting result.